Brisbane, CA, United States of America

Aimmune Therapeutics, Inc.


USPTO Granted Patents = 10


Forward Citations = 118

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Howard V Raff (7 out of 12 patents)

silverMedal Bryan Walser (6 out of 9 patents)

bronzeMedal Kristin Bennett (3 out of 4 patents)

4.  Michael S Holfinger (3 out of 4 patents)

5.  Naomi Korn Gold (3 out of 4 patents)

6.  Christine Horan (3 out of 10 patents)

7.  Michel Arney (3 out of 4 patents)


10 patents:

Company Overview
Aimmune Therapeutics, Inc. is a biopharmaceutical company based in Brisbane, California, focused on developing treatments for food allergies. The company specializes in innovative therapies that aim to desensitize patients to allergens, enhancing their quality of life and safety. Aimmune's research is centered on immunotherapy, leveraging its proprietary technology to create effective solutions for managing food allergies, particularly peanut allergies, in both pediatric and adult populations.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Aimmune Therapeutics, Inc. USPTO Patent Assignee Logo
10 Patents

#17 in Brisbane, CA

#7,114 in California

#29,866 in US

#56,047 in the World

Brisbane, CA (US)
Brisbane, CA, United States of America
Forward Citations = 118

7 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aimmune Therapeutics, Inc.. Retrieved from https://idiyas.com/company/aimmune-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…